deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT02369432

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis (MicroIskin)

Sponsor: Centre Hospitalier Universitaire de Besancon

Updated 7 times since 2017 Last updated: Oct 12, 2017 Started: Feb 20, 2015 Primary completion: Oct 3, 2017 Completion: Oct 3, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulties in enrolling patients

Listed as NCT02369432, this EARLY_PHASE1 trial focuses on Atopic Dermatitis and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

  5. Oct 2017 — Jun 2018 [monthly]

    Terminated EARLY_PHASE1

    Status: RecruitingTerminated

Show 2 earlier versions
  1. Feb 2017 — Oct 2017 [monthly]

    Recruiting EARLY_PHASE1

    Phase: Phase 0EARLY_PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Recruiting Phase 0

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Besancon
  • University of Franche-Comté
Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations